Transmissible spongiform encephalopathies in humans;Transmissible spongiforme Enzephalopathien beim Menschen

Schweizer Archiv fur Tierheilkunde

Volumn 144, Issue 12, 2002, Pages 685-690

  Rogivue, C ^a   Gottwein, J ^b   Aguzzi, A ^b   Glatzel, M ^b  

^a Bundesamt für Gesundheit BAG   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

BSE; Prion; Sporadic Creutzfeldt Jakob disease (sCID); TSE; Variant of Creutzfeldt Jakob disease (vCJD)

Indexed keywords

ANIMAL; BOVINE SPONGIFORM ENCEPHALOPATHY; BRAIN; CATTLE; CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; HUMAN; PATHOLOGY; PRION DISEASE; REVIEW; SWITZERLAND; ZOONOSIS;

ANIMALS; BRAIN; CATTLE; CREUTZFELDT-JAKOB SYNDROME; ENCEPHALOPATHY, BOVINE SPONGIFORM; HUMANS; PRION DISEASES; SWITZERLAND; ZOONOSES;

EID: 0036986039     PISSN: 00367281     EISSN: None     Source Type: Journal    
DOI: 10.1024/0036-7281.144.12.685     Document Type: Article

References (23)

1. Aguzzi A., Glatzel M., Montrasio F., Prinz M., Heppner F.L.: Interventional strategies against prion diseases. Nat. Rev. Neurosci. 2001, 2. 745-9.
2. Brown P., Preece M., Brandel J.P., Sato T., Mcshane L., Zerr I., Fletcher A., Will R. G., Pocchiari M., Cashman N.R., D'aignaux J.H., Cervenakova L., Fradkin J., Schonberger L. B., Collins S.J.: Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 2000, 55:1075-81.
3. Collinge J., Sidle K.C., Meads J., Ironside J., Hill A.F.: Molecular analysis of priori strain Variation and the aetiology of 'new variant' CJD. Nature 1996, 383:685-90.
4. Collins S., Boyd A., Fletcher A., Byron K., Harper C., Mclean C.A., Masters C.L.: Novel prion protein gene mutation in an octogenarian with Creutzfeldt-Jakob disease. Arch. Neurol. 2000, 57:1058-63.
5. Consens S.N., Linsell L., Smith P.G., Chandrakumar M., Wilesmith J. W., Knight R.S., Zeidler M., Stewart G., Will R. G.: Geographical distribution of variant CJD in the UK (excluding Northern Ireland). Lancet 1999, 353:18-21.
6. Ghani A.C., Ferguson N.M., Donnelly C.A., Anderson R.M.: Predicted vCJD mortality in Great Britain. Nature 2000, 406:583-4.
7. Glatzel M., Rogivue C., Ghani A., Streffer J., Amsler L., Aguzzi A.: Incidence of Creutzfeldt-Jakob disease in Switzerland. Lancet 2002, 360:139-141.
8. Heppner F.L., Aguzzi A.: Immunity against prions? Dtsch. Med.Wochenschr. 2002, 127:328-30.
9. Heppner F.L., Musahl C., Arrighi I., Klein M.A., Rulicke T, Oesch B., Zinkernagel R.M., Kalinke U., Aguzzi A.: Prevention of Scrapie Pathogenesis by Transgenic Expression of Anti-Prion Protein Antibodies. Science 2001, 294:178-182.
10. Hill A.F., Butterworth R.J., Joiner S., Jackson G., Rossor M.N.,Thomas D.J., Frosh A., Tolley N., Bell J.E., Spencer M., King A., Al-Sarraj S., Ironside J. W., Lantos P.L., Collinge J.: Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 1999, 353: 183-9.
11. Hill A.F., Desbruslais M., Joiner S., Sidle K. C., Gowland I., Collinge J., Doey L.J., Lantos P.. The same prion strain causes vCJD and BSE [letter] [see comments]. Nature 1997, 389:448-50.
12. Http://www.Bag.Admin.Ch/Infekt/Krank/D/ Creuzfeldt.Htm, BAG (2002): Creutzfeldt-Jakob.
13. Http://www.Cjd.Ed.Ac.Uk/Protocol.Html, National CJD Surveillance Unit (2002): National Creutzfeldt Jakob disease surveillance protocol.
14. Http://www.Doh.Gov.Uk/Cjd/Stats/Aug02.Htm, Department of Health (2002): Monthly Creutzfeldt-Jakob disease statistics.
15. Http://www.Eurocjd.Ed.Ac.Uk/Euroindex.Htm, Jan Mackenzie, National CJD Surveillance Unit, Western General Hospital, Edinburgh (2002): The European and Allied Countries Collaborative Study Group of CJD (EUROCJD).
16. Http:www.Oie.Int/Status/a_Bse.Htm. Number of reported cases of BSE worldwide.
17. Jakob A.: Uber eigenartige Erkrankungen des Zentralnervensystems mit bemerkenswertem anatomischem Befunde (Spastische Pseudosklerose-Encepha-lomyelopathie mit disseminierten Degenerationsherden). Z. ges. Neurol. Psychiatr. 1921, 64:147-228.
18. Lasmezas C.I., Deslys J.P., Demaimay R., Adjou K. T., Lamoury F., Dormont D., Robain O., Ironside J., Hauw J.J.:Bse Transmission to Macaques. Nature 1996, 381:743-744.
19. Parchi P., Capellari S., Chin S., Schwarz H.B., Schecter N.P., Butts J.D., Hudkins P., Burns D.K., Powers J.M., Gambetti P.: A subtype of sporadic prion disease mimicking fatal familial insomnia. Neurology 1999, 52:1757-63.
20. Volleron A.J., Boelle P.Y., Will R., Cesbron J.Y.: Estimation of epidemic size and incubation time based on age characteristics of vCJD in the United Kingdom. Science 2001, 294:1726-8.
21. Will R.G., Ironside J. W., Zeidler M., Consens S.N., Estibeiro K., Alperovitch A., Poser S., Pocchiari M., Hofman A., Smith: A. new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996, 347:921-925.
22. Zeidler M., Stewart G.E., Barraclough C.R., Bateman D.E., Bates D., Burn D.J., Colchester A.C., Durward W., Fletcher N.A., Hawkins S.A., Mackenzie J M., Will R G.: New variant Creutzfeldt-Jakob disease: neurological features and diagnostic tests. Lancet 1997, 350:903-7.
23. Zigas V., Gajdusek D. C.: Kuru: Clinical study of a new syndrome resembling paralysis agitans in natives of the Eastern Highlands of Australian New Guinea. Med. J. Austral. 1957, 2:745-754.